Logo image of LXU

LSB INDUSTRIES INC (LXU) Stock Fundamental Analysis

NYSE:LXU - New York Stock Exchange, Inc. - US5021601043 - Common Stock - Currency: USD

6.38  +0.3 (+4.93%)

Premarket: 6.4 +0.02 (+0.31%)

Fundamental Rating

3

Taking everything into account, LXU scores 3 out of 10 in our fundamental rating. LXU was compared to 85 industry peers in the Chemicals industry. While LXU seems to be doing ok healthwise, there are quite some concerns on its profitability. LXU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year LXU was profitable.
In the past year LXU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LXU reported negative net income in multiple years.
Of the past 5 years LXU 4 years had a positive operating cash flow.
LXU Yearly Net Income VS EBIT VS OCF VS FCFLXU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

LXU's Return On Assets of -1.63% is on the low side compared to the rest of the industry. LXU is outperformed by 68.24% of its industry peers.
LXU has a Return On Equity of -3.94%. This is in the lower half of the industry: LXU underperforms 64.71% of its industry peers.
Industry RankSector Rank
ROA -1.63%
ROE -3.94%
ROIC N/A
ROA(3y)5.51%
ROA(5y)-2.47%
ROE(3y)15.37%
ROE(5y)-5.05%
ROIC(3y)N/A
ROIC(5y)N/A
LXU Yearly ROA, ROE, ROICLXU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

With a Gross Margin value of 9.15%, LXU is not doing good in the industry: 83.53% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of LXU has grown nicely.
LXU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.46%
GM growth 5Y46.21%
LXU Yearly Profit, Operating, Gross MarginsLXU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

LXU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LXU has less shares outstanding
The number of shares outstanding for LXU has been increased compared to 5 years ago.
The debt/assets ratio for LXU has been reduced compared to a year ago.
LXU Yearly Shares OutstandingLXU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXU Yearly Total Debt VS Total AssetsLXU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

LXU has an Altman-Z score of 1.26. This is a bad value and indicates that LXU is not financially healthy and even has some risk of bankruptcy.
LXU has a Altman-Z score of 1.26. This is in the lower half of the industry: LXU underperforms 67.06% of its industry peers.
LXU has a Debt/Equity ratio of 0.99. This is a neutral value indicating LXU is somewhat dependend on debt financing.
LXU has a worse Debt to Equity ratio (0.99) than 68.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF N/A
Altman-Z 1.26
ROIC/WACCN/A
WACC8.62%
LXU Yearly LT Debt VS Equity VS FCFLXU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

LXU has a Current Ratio of 2.28. This indicates that LXU is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.28, LXU is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
A Quick Ratio of 2.10 indicates that LXU has no problem at all paying its short term obligations.
LXU has a Quick ratio of 2.10. This is amongst the best in the industry. LXU outperforms 83.53% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 2.1
LXU Yearly Current Assets VS Current LiabilitesLXU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.67% over the past year.
The Revenue for LXU has decreased by -12.01% in the past year. This is quite bad
Measured over the past years, LXU shows a small growth in Revenue. The Revenue has been growing by 7.43% on average per year.
EPS 1Y (TTM)36.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.38%
Revenue 1Y (TTM)-12.01%
Revenue growth 3Y-2.07%
Revenue growth 5Y7.43%
Sales Q2Q%3.78%

3.2 Future

LXU is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.84% yearly.
Based on estimates for the next years, LXU will show a small growth in Revenue. The Revenue will grow by 3.23% on average per year.
EPS Next Y-42.29%
EPS Next 2Y2.57%
EPS Next 3Y-8.84%
EPS Next 5YN/A
Revenue Next Year10.4%
Revenue Next 2Y7.29%
Revenue Next 3Y5.57%
Revenue Next 5Y3.23%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LXU Yearly Revenue VS EstimatesLXU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
LXU Yearly EPS VS EstimatesLXU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.56 indicates a correct valuation of LXU.
The rest of the industry has a similar Price/Earnings ratio as LXU.
The average S&P500 Price/Earnings ratio is at 28.88. LXU is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 10.83, the valuation of LXU can be described as very reasonable.
Based on the Price/Forward Earnings ratio, LXU is valued a bit cheaper than 75.29% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.20, LXU is valued a bit cheaper.
Industry RankSector Rank
PE 15.56
Fwd PE 10.83
LXU Price Earnings VS Forward Price EarningsLXU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LXU is valued a bit cheaper than the industry average as 63.53% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.03
LXU Per share dataLXU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

LXU's earnings are expected to decrease with -8.84% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.57%
EPS Next 3Y-8.84%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LXU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LSB INDUSTRIES INC

NYSE:LXU (4/30/2025, 8:19:24 PM)

Premarket: 6.4 +0.02 (+0.31%)

6.38

+0.3 (+4.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners53.58%
Inst Owner Change0.23%
Ins Owners4.27%
Ins Owner Change0.2%
Market Cap458.59M
Analysts77.78
Price Target8.98 (40.75%)
Short Float %3.36%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)117.57%
Min EPS beat(2)100%
Max EPS beat(2)135.15%
EPS beat(4)4
Avg EPS beat(4)127.48%
Min EPS beat(4)100%
Max EPS beat(4)166.32%
EPS beat(8)5
Avg EPS beat(8)32.51%
EPS beat(12)7
Avg EPS beat(12)14.94%
EPS beat(16)9
Avg EPS beat(16)28.75%
Revenue beat(2)2
Avg Revenue beat(2)13.18%
Min Revenue beat(2)12.81%
Max Revenue beat(2)13.55%
Revenue beat(4)3
Avg Revenue beat(4)6.73%
Min Revenue beat(4)-6.62%
Max Revenue beat(4)13.55%
Revenue beat(8)7
Avg Revenue beat(8)4.64%
Revenue beat(12)9
Avg Revenue beat(12)3.6%
Revenue beat(16)10
Avg Revenue beat(16)2.57%
PT rev (1m)-12.44%
PT rev (3m)-10.2%
EPS NQ rev (1m)-23.81%
EPS NQ rev (3m)-61.91%
EPS NY rev (1m)236.84%
EPS NY rev (3m)-26.15%
Revenue NQ rev (1m)-1.7%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)2.88%
Revenue NY rev (3m)2.78%
Valuation
Industry RankSector Rank
PE 15.56
Fwd PE 10.83
P/S 0.88
P/FCF N/A
P/OCF 5.3
P/B 0.93
P/tB 0.94
EV/EBITDA 8.03
EPS(TTM)0.41
EY6.43%
EPS(NY)0.59
Fwd EY9.23%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)1.2
OCFY18.88%
SpS7.27
BVpS6.84
TBVpS6.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.63%
ROE -3.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.15%
FCFM N/A
ROA(3y)5.51%
ROA(5y)-2.47%
ROE(3y)15.37%
ROE(5y)-5.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.46%
GM growth 5Y46.21%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF N/A
Debt/EBITDA 6.58
Cap/Depr 124.26%
Cap/Sales 17.67%
Interest Coverage N/A
Cash Conversion 116.72%
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 2.1
Altman-Z 1.26
F-Score4
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)96.58%
Cap/Depr(5y)76.59%
Cap/Sales(3y)11.38%
Cap/Sales(5y)9.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.38%
EPS Next Y-42.29%
EPS Next 2Y2.57%
EPS Next 3Y-8.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.01%
Revenue growth 3Y-2.07%
Revenue growth 5Y7.43%
Sales Q2Q%3.78%
Revenue Next Year10.4%
Revenue Next 2Y7.29%
Revenue Next 3Y5.57%
Revenue Next 5Y3.23%
EBIT growth 1Y-100.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2157.36%
EBIT Next 3Y195.04%
EBIT Next 5Y92.67%
FCF growth 1Y-108.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.05%
OCF growth 3Y-0.4%
OCF growth 5Y110.4%